机译:氨基异氧唑作为色氨酸2,3-二恶英酶2(TDO2)的有效抑制剂
Department of Discovery Chemistry Department of Biochemical and Cellular Pharmacology Department of Drug Metabolism and Pharmacokinetics and Department of Translational Oncology Genentech Inc. 1 DNA Way South San Francisco California 94080 United;
Department of Discovery Chemistry Department of Biochemical and Cellular Pharmacology Department of Drug Metabolism and Pharmacokinetics and Department of Translational Oncology Genentech Inc. 1 DNA Way South San Francisco California 94080 United;
Department of Discovery Chemistry Department of Biochemical and Cellular Pharmacology Department of Drug Metabolism and Pharmacokinetics and Department of Translational Oncology Genentech Inc. 1 DNA Way South San Francisco California 94080 United;
Department of Discovery Chemistry Department of Biochemical and Cellular Pharmacology Department of Drug Metabolism and Pharmacokinetics and Department of Translational Oncology Genentech Inc. 1 DNA Way South San Francisco California 94080 United;
Department of Discovery Chemistry Department of Biochemical and Cellular Pharmacology Department of Drug Metabolism and Pharmacokinetics and Department of Translational Oncology Genentech Inc. 1 DNA Way South San Francisco California 94080 United;
Department of Discovery Chemistry Department of Biochemical and Cellular Pharmacology Department of Drug Metabolism and Pharmacokinetics and Department of Translational Oncology Genentech Inc. 1 DNA Way South San Francisco California 94080 United;
Department of Discovery Chemistry Department of Biochemical and Cellular Pharmacology Department of Drug Metabolism and Pharmacokinetics and Department of Translational Oncology Genentech Inc. 1 DNA Way South San Francisco California 94080 United;
Department of Discovery Chemistry Department of Biochemical and Cellular Pharmacology Department of Drug Metabolism and Pharmacokinetics and Department of Translational Oncology Genentech Inc. 1 DNA Way South San Francisco California 94080 United;
Department of Discovery Chemistry Department of Biochemical and Cellular Pharmacology Department of Drug Metabolism and Pharmacokinetics and Department of Translational Oncology Genentech Inc. 1 DNA Way South San Francisco California 94080 United;
Department of Discovery Chemistry Department of Biochemical and Cellular Pharmacology Department of Drug Metabolism and Pharmacokinetics and Department of Translational Oncology Genentech Inc. 1 DNA Way South San Francisco California 94080 United;
Pharmaron-Beijing Co. Ltd. 6 Taihe Road BDA Beijing 100176 P. R. China;
Pharmaron-Beijing Co. Ltd. 6 Taihe Road BDA Beijing 100176 P. R. China;
Pharmaron-Beijing Co. Ltd. 6 Taihe Road BDA Beijing 100176 P. R. China;
Pharmaron-Beijing Co. Ltd. 6 Taihe Road BDA Beijing 100176 P. R. China;
Department of Discovery Chemistry Department of Biochemical and Cellular Pharmacology Department of Drug Metabolism and Pharmacokinetics and Department of Translational Oncology Genentech Inc. 1 DNA Way South San Francisco California 94080 United;
Department of Discovery Chemistry Department of Biochemical and Cellular Pharmacology Department of Drug Metabolism and Pharmacokinetics and Department of Translational Oncology Genentech Inc. 1 DNA Way South San Francisco California 94080 United;
Cancer immunotherapy; enzyme; heme; IDO; TDO;
机译:氨基异氧唑作为色氨酸2,3-二恶英酶2(TDO2)的有效抑制剂
机译:新型色氨酸2,3-双加氧酶2(TDO2)小分子抑制剂的临床前评估
机译:吲哚胺-2,3-二加氧酶的羟y胺抑制剂可有效抑制全身色氨酸分解代谢和表达IDO的肿瘤的生长。
机译:阿尔茨海默氏病:无标记的荧光显示大脑受影响区域的吲哚胺2,3-双加氧酶(IDO)或色氨酸2,3-双加氧酶(TDO)活性增加
机译:第一部分。具有吲哚胺2,3-二加氧酶抑制剂潜在活性的旋光色氨酸衍生物的合成:一种通过不对称催化氢化的方法。第二部分。含α1的GABA(A)/苯并二氮杂receptor受体亚型的选择性配体的设计,合成和药理作用:位于-3和-6位的β-咔啉及其相应的二价配体的SAR研究。第三部分。重要生物遗传中间体,(+)-聚神经氨酸和(+)-聚神经氨酸醛,以及16-表-维西辛和Macusine A的首次对映体全合成。
机译:氨基异恶唑作为色氨酸的强效抑制剂23-双加氧酶2(TDO2)
机译:干扰素△(IFN-α)基因签名和色氨酸2,3-二氧合酶2(TDO2)基因表达:用于Linrodostat甲磺酸盐的潜在预测复合生物标志物(BMS-986205;吲哚胺2,3-二氧化酶1抑制剂IDO1i)+ Nivolumab (NIVO)